NCT02630446

Brief Summary

The general objective of this quasi-experimental study is to assess the effectiveness of an in-home respite care program compared to a control group not receiving the same type of in-home respite on the well-being of the caregiver, the care-recipient and on the healthcare system. The latter in terms of resource use, intention to institutionalize the care-recipient and time to nursing home placement. A quasi-experimental study will be designed. The intervention group will consist of caregiver/care-recipient dyads receiving an in-home respite program called "Baluchonnage" and will be compared to a control group that doesn't receive "Baluchonnage". Comparison between the groups will be done by collecting health related and economic data. The trial will evaluate outcomes as well in the caregiver as in the care recipient (measured via the caregiver). The primary research outcome is caregiver burden. Secondary outcomes for caregivers are: health related quality of life and reactions to behavioral problems of the care-recipient. A secondary outcome related to the care-recipient is: frequency of behavioral problems. Secondary outcomes for the healthcare system are: intention to institutionalize the recipient into a nursing home and resource use of the recipient. Finally, in a follow up phase of the trial possible differences in time to nursing home placement will be measured (as well as burden and intention to institutionalize. Additionally, willingness to pay for "Baluchonnage" per day will be asked to the informal caregivers. Eventually, if the intervention is effective, modeled and trial based cost-effectiveness analyses will be undertaken in a separate economic evaluation plan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
355

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 15, 2015

Completed
17 days until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

April 24, 2019

Status Verified

April 1, 2019

Enrollment Period

2.4 years

First QC Date

November 24, 2015

Last Update Submit

April 23, 2019

Conditions

Keywords

respite careeffectivenesscost-effectivenesssupportcaregiverdementiacommunity-based

Outcome Measures

Primary Outcomes (1)

  • Change in burden of caregivers measured using the Zarit Burden Interview-short version

    Burden will be measured using the Zarit Burden Interview-short version (ZBI) which is a 22-item validated self-report questionnaire developed to examine subjective burden of caregivers of people with dementia.

    Assessments over 12 months: T0 = baseline (inclusion), T1 = 14 days after intervention (only intervention group), T3 = T0 + 6 months and T4 = T0 + 12 months.

Secondary Outcomes (6)

  • Health related quality of life measured using the EQ-5D-5L

    T0 = baseline (inclusion) and T2 = T0 + 6 months.

  • Frequency of problematic behaviors in care-recipient (RMBPC)

    T0 = baseline (inclusion), T1 = 14 days after intervention (only intervention group), T2 = T0 + 6 months

  • Reaction of caregiver to behavioral problems (RMBPC)

    T0 = baseline (inclusion), T1 = 14 days after intervention (only intervention group), T2 = T0 + 6 months

  • Intention to institutionalize assessed using Desire To Institutionalize scale

    T0 = baseline (inclusion), T1 = 14 days after intervention (only intervention group), T3 = T0 + 6 months and T4 = T0 + 12 months.

  • Time to nursing home placement

    T3 = T0 + 12 months

  • +1 more secondary outcomes

Study Arms (2)

in-home respite care program

EXPERIMENTAL

During the respite care period, lasting at least five days, a trained or experienced care worker for persons with dementia takes over all caregiving tasks while the informal caregiver is absent. The care worker thus temporary moves into the house of the person with dementia. The care worker also writes down his/her observations in a diary as well as daily experiences and strategies on how to manage the difficult behaviors the caregivers listed before. So additionally to the provision of respite, this program also includes caregiver support and psycho-education. This support enables the caregiver to validate theirs perceptions, to learn how to deal with difficult behaviors and to feel understood by somebody.

Other: in-home respite care program

standard dementia care

NO INTERVENTION

Control group receiving all types of standard dementia care except in-home respite care of the Baluchon type.

Interventions

During the respite care period, lasting at least five days, a trained or experienced care worker for persons with dementia takes over all caregiving tasks while the informal caregiver is absent. The care worker thus temporary moves into the house of the person with dementia. The care worker also writes down his/her observations in a diary as well as daily experiences and strategies on how to manage the difficult behaviors the caregivers listed before. So additionally to the provision of respite, this program also includes caregiver support and psycho-education. This support enables the caregiver to validate theirs perceptions, to learn how to deal with difficult behaviors and to feel understood by somebody.

Also known as: intervention group
in-home respite care program

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The study participants are caregiver/care-recipient dyads.
  • The caregivers must be informal, meaning that they must not be professional healthcare workers in this caregiving role.
  • The caregivers have to identify themselves as the main person responsible for the informal care (primary caregiver).
  • Also, the caregivers must speak Dutch or French with some fluency and be able to read and write.
  • The care-recipient needs to be diagnosed with dementia based on the criteria of DSM fourth edition (Diagnostic and Statistical Manual of Mental Disorders) and must live in the community.

You may not qualify if:

  • Caregivers will be excluded if they have cognitive impairments or severe psychiatric comorbidities.
  • Control group dyads who already utilized in-home respite care of the Baluchon type will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University-Public Health Department

Ghent, East-Flanders, 9000, Belgium

Location

Related Publications (3)

  • Vandepitte S, Van Wilder L, Putman K, Van Den Noortgate N, Verhaeghe S, Trybou J, Annemans L. Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study. BMC Geriatr. 2020 Jan 16;20(1):18. doi: 10.1186/s12877-020-1414-6.

  • Vandepitte S, Putman K, Van Den Noortgate N, Verhaeghe S, Annemans L. Effectiveness of an in-home respite care program to support informal dementia caregivers: A comparative study. Int J Geriatr Psychiatry. 2019 Oct;34(10):1534-1544. doi: 10.1002/gps.5164. Epub 2019 Jul 11.

  • Vandepitte S, Van Den Noortgate N, Putman K, Verhaeghe S, Annemans L. Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia: design of a comparative study. BMC Geriatr. 2016 Dec 2;16(1):207. doi: 10.1186/s12877-016-0373-4.

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Lieven Annemans, PhD

    University Ghent

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2015

First Posted

December 15, 2015

Study Start

January 1, 2016

Primary Completion

June 1, 2018

Study Completion

December 1, 2018

Last Updated

April 24, 2019

Record last verified: 2019-04

Locations